CELU News and Press, Celularity Inc. From 09/02/25

A look at the top 10 most actives in the United States Opendoor Technologies Inc (OPEN) rose 14.4% to $5.09 on volume of 404,498,958 shares Carisma Therapeutics Inc. (CARM) rose 104.7% to $0.44 on volume of 369,969,532 shares HWH International Inc. (HWH) rose 227.8% to $4.72 on volume of 31...

A look at the top 10 most actives in the United States Carisma Therapeutics Inc. (CARM) rose 125.7% to $0.4853 on volume of 187,473,914 shares Cycurion Inc. (CYCU) rose 12.2% to $0.2246 on volume of 82,960,205 shares Actelis Networks Inc (ASNS) rose 57.6% to $0.5705 on volume of 74,386,133 ...

A look at the top 10 most actives in the United States Opendoor Technologies Inc (OPEN) rose 36.4% to $2.25 on volume of 547,098,005 shares Incannex Healthcare Inc. (IXHL) rose 64.8% to $0.61 on volume of 472,694,351 shares Bit Origin Limited (BTOG) rose 23.6% to $0.78 on volume of 357,677,...

Fountain Life operates four flagship longevity centers, including two in Florida, where a new state law effective July 1, 2025, authorizes licensed physicians to administer stem cell therapies to members with conditions in orthopedics, wound care, and pain management. FLORHAM PARK, N.J., Ju...

2025-07-06 18:46:23 ET Celularity Inc. (CELU) - This analysis reviews how the stock price reacted during the last 12 earnings periods. The average open to high on the day of earnings was 6.45%. The average open to low on the day of earnings was -4.97%. The average open to close ...

2025-07-06 18:41:22 ET Celularity Inc. (CELU) - Following Earnings Price Analysis was done using last 12 quarters historical earnings. Opening Gap Moves The historical opening gap move in CELU stock price following earnings has averaged ±4.16% , with a median of 3.34%. The ...

New law goes into effect on July 1 st authorizing Florida physicians to provide stem cell therapies to their patients for orthopedics, wound care, and pain management FLORHAM PARK, N.J., July 01, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or th...

2025-06-10 16:21:44 ET Read the full article on Seeking Alpha For further details see: CELU announces CFO termination; appoints interim incharge

FLORHAM PARK, N.J., June 10, 2025 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity” or the “Company”), a regenerative and cellular medicine company, today announced that it terminated the employment of its Chief Financial Officer (“CFO”), D...

Highlights the unique potential of Celularity’s proprietary advanced biomaterial technology as a novel cellular delivery system for ocular surface reconstruction Supports broad range of regenerative medicine applications beyond ophthalmology FLORHAM PARK, N.J., June 02, 2025 (G...